RGNX logo

REGENXBIO (RGNX) Company Overview

Profile

Full Name:

REGENXBIO Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 17, 2015

Indexes:

Not included

Description:

REGENXBIO Inc. is a clinical-stage biotechnology company that provides gene therapy product candidates designed to address genetic defects in cells and enable the cells of the body to produce therapeutic proteins or antibodies that target the disease. The company was founded in 2008 and is headquartered in Rockville, Maryland. The company has developed a wide range of gene therapy programs using its proprietary NAV technology platform to address genetic diseases. REGENXBIO Inc. also licenses its NAV technology platform to other biotechnology and pharmaceutical companies, and has a collaboration and licensing agreement with Neurimmune AG for the development of vectorized antibodies for the treatment of neurodegenerative diseases.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 11, 25 Goldman Sachs
Neutral
Jan 21, 25 RBC Capital
Outperform
Jan 15, 25 HC Wainwright & Co.
Buy
Dec 11, 24 RBC Capital
Outperform
Nov 21, 24 HC Wainwright & Co.
Buy
Nov 20, 24 Chardan Capital
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Oct 22, 24 Chardan Capital
Buy
Sep 4, 24 HC Wainwright & Co.
Buy
Aug 5, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for REGENXBIO?
  • Does REGENXBIO pay dividends?
  • What sector is REGENXBIO in?
  • What industry is REGENXBIO in?
  • What country is REGENXBIO based in?
  • When did REGENXBIO go public?
  • Is REGENXBIO in the S&P 500?
  • Is REGENXBIO in the NASDAQ 100?
  • Is REGENXBIO in the Dow Jones?
  • When was REGENXBIO's last earnings report?
  • When does REGENXBIO report earnings?
  • Should I buy REGENXBIO stock now?

What is the ticker symbol for REGENXBIO?

The ticker symbol for REGENXBIO is NASDAQ:RGNX

Does REGENXBIO pay dividends?

No, REGENXBIO does not pay dividends

What sector is REGENXBIO in?

REGENXBIO is in the Healthcare sector

What industry is REGENXBIO in?

REGENXBIO is in the Biotechnology industry

What country is REGENXBIO based in?

REGENXBIO is headquartered in United States

When did REGENXBIO go public?

REGENXBIO's initial public offering (IPO) was on September 17, 2015

Is REGENXBIO in the S&P 500?

No, REGENXBIO is not included in the S&P 500 index

Is REGENXBIO in the NASDAQ 100?

No, REGENXBIO is not included in the NASDAQ 100 index

Is REGENXBIO in the Dow Jones?

No, REGENXBIO is not included in the Dow Jones index

When was REGENXBIO's last earnings report?

REGENXBIO's most recent earnings report was on Feb 27, 2025

When does REGENXBIO report earnings?

The date for REGENXBIO's next earnings report has not been announced yet

Should I buy REGENXBIO stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions